Patient info

Invita D3 7 000 IU soft capsules – patient leaflet, side effects, dosage

Updated:
Medicine strength:
7 000 IU
Contains active substance:

Patient leaflet - Invita D3 7 000 IU soft capsules

1. WHAT INVITA D3 IS AND WHAT IT IS USED FOR

InVita D3 contains colecalciferol (vitamin D3). Vitamin D can be found in some foods and is also produced by the body when skin is exposed to sunlight. Vitamin D3 helps the kidneys and intestine absorb calcium and it helps build bones. InVita D3 is used:

  • to prevent vitamin D deficiency when there is a significant risk of deficiency or an increased demand for vitamin D
  • with other medicine to treat certain bone conditions, such as thinning of the bone (osteoporosis).
  • to treat vitamin D deficiency that has been confirmed by laboratory tests.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE INVITA D3

Do not take InVita D3:

  • if you are allergic to vitamin D or any of the other ingredients of this medicine (listed in section 6);
  • if you have high levels of calcium in your blood (hypercalcaemia) or urine (hypercalciuria);
  • if you have kidney stones (renal calculi);
  • if you have high levels of vitamin D in your blood (hypervitaminosis D)

If any of the above applies to you, talk to your doctor or pharmacist before taking InVita D3.

Warnings and precautions

Talk to your doctor or pharmacist before taking InVita D3 if you:

  • are undergoing treatment with certain medicines used to treat heart disorders (e.g, cardiac glycosides, such as digoxin);
  • have sarcoidosis (an immune system disorder which may cause increased levels of vitamin D in the body);
  • are taking medicines containing vitamin D, or eating foods or milk enriched with vitamin D;
  • are likely to be exposed to a lot of sunshine whilst using InVita D3;

    PACKAGE LEAFLET: INFORMATION FOR THE USER

    InVita D3 1,000 IU soft capsules InVita D3 7,000 IU soft capsules

    colecalciferol (vitamin D3)

    • take additional supplements containing calcium. Your doctor will monitor your blood levels of calcium to make sure they are not too high whilst you are using InVita D3;
    • have kidney damage or disease. Your doctor may want to measure the levels of calcium in your blood or urine. Children

This medicine is not suitable for use in children under 10 years of age.

Other medicines and InVita D3

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. This is especially important if you are taking:

  • medicines that act on the heart or kidneys, such as cardiac glycosides (e.g. digoxin) or diuretics (e.g. bendroflumethazide). When used at the same time as vitamin D these medicines may cause a large increase in the level of calcium in the blood and urine;
  • medicines containing vitamin D or eating food rich in vitamin D, such as, some types of vitamin D-enriched milk;
  • actinomycin (a medicine used to treat some forms of cancer) and imidazole antifungals (e.g. clotrimazole and ketoconazole, medicines used to treat fungal disease). These medicines may interfere with the way your body process vitamin D;
  • the following medicines because they can interfere with the effect or the absorption of vitamin D:

    • antiepileptic medicines (anticonvulsants), barbiturates;
    • glucocorticoids (steroid hormones such as hydrocortisone or prednisolone). These can decrease the effect of vitamin D;
    • medicines that lower the level of cholesterol in the blood (such as cholestyramine, or colestipol);
    • certain medicines for weight loss that reduce the amount of fat your body absorbs (e.g. orlistat);
    • certain laxatives (such as liquid paraffin). InVita D3 with food and drink

See section 3 “How to take InVita D3”.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Driving and using machines

There is limited information on the possible effects of this medicine on your ability to drive. However, it is not expected that it would affect your ability to drive or to operate machinery.

InVita D3 contains Allura Red AC (E129) and Sunset Yellow FCF (E110)

InVita D3 1,000 IU soft capsules contain Allura Red AC (E129) which may cause allergic reactions.

InVita D3 7,000 IU soft capsules contain Sunset Yellow FCF (E110) which may cause allergic reactions.

If you are allergic to the above colouring agents, consult your doctor or pharmacist.

Client : Consilient Health Ltd.

Project : Dec 2023

Item(s) : InVita D3 7,000 IU soft capsules

Size : 160 x 240 mm

Software : InDesign CC

FONTS

Myriad Pro

BiomeW01-Regular

DESIGNED BY

Minty

PLEASE NOTE : PAPER COPIES ARE SUPPLIED AS A VISUAL REFERENCE ONLY. DO NOT MATCH FOR COLOUR

CONSILIENT CODE : P1659

3. HOW TO TAKE INVITA D3

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The capsules should be swallowed whole with water. You should take InVita D3 preferably together with a large meal to help your body absorb the vitamin D3. Dosage

1,000 IU soft capsules

Your doctor will usually prescribe these soft capsules daily. 7,000 IU soft capsules

Your doctor will usually prescribe these soft capsules weekly. Use in adults

The recommended dose for:

Prevention of vitamin D deficiency: 1,000 IU/day Treatment of vitamin D deficiency: 1,000 IU - 4,000 IU/day for up to 12 weeks, followed by maintenance therapy of 1,400 IU - 2,000 IU/day (such as two 1,000 IU soft capsules per day or two 7,000 IU soft capsules per week). Addition to specific therapy for osteoporosis: 1,000 IU/day Use in children and adolescents

The recommended dose for:

  • Prevention of deficiency 10-18 years: doses of up to 1,000 IU/day may be required to prevent deficiency in some children.
  • Treatment of deficiency 10-18 years: 2,000 IU/day for 6 weeks followed by a maintenance therapy of 400 IU- 1,000 IU/day (such as one 1,000 IU soft capsule per day or one 7,000 IU soft capsule per week).

Use in pregnancy and breast-feeding

The recommended dose for:

Prevention of deficiency:

Doses of 1,000 IU – 2,000 IU /day may be required to prevent deficiency in some women.

Even higher doses may be required in breast-feeding if women choose not to give the infant a vitamin D supplement. If you take more InVita D3 than you should

If you or your child take more medicine than prescribed, stop using this medicine and contact your doctor. If it is not possible to talk to a doctor go to the nearest hospital emergency department and take the medicine package with you.

The most common symptoms of overdose are: nausea, vomiting, excessive thirst, the production of large amounts of urine over 24 hours, constipation and dehydration, high levels of calcium in the blood (hypercalcaemia and hypercalciuria) shown by lab test.

If you forget to take InVita D3

If you forget to take a dose of InVita D3, take the forgotten dose as soon as possible. Then take the next dose at the correct time. However, if it is almost time to take the next dose, do not take the dose you have missed; just take the next dose as normal.

Do not take a double dose to make up for a forgotten dose. If you stop taking InVita D3

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Possible side effects may include:

Uncommon (may affect up to 1 in 100 people)

  • Too much calcium in your blood (hypercalcaemia)
  • Too much calcium in your urine (hypercalciuria)

    Rare (may affect up to 1 in 1,000 people)

    • Skin rash
    • Itching
    • Hives

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE INVITA D3

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton after “Exp”. The expiry date refers to the last day of that month.

Do not store above 25°C.

Store in the original packaging in order to protect from light. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What InVita D3 contains

  • The active substance is colecalciferol (vitamin D3). InVita D3 1,000 IU soft capsules

    Each capsule contains 1,000 IU of colecalciferol (vitamin D3) equivalent to 0.025 mg.

  • The other ingredients are: all-rac-α-tocopherol (E307), medium chain triglycerides, glycerol, gelatine, Opacode® White imprinting ink (consisting of: shellac (E904), titanium dioxide (E171) and simethicone), Allura Red AC (E129). InVita D3 7,000 IU soft capsules

    Each capsule contains 7,000 IU of colecalciferol (vitamin D3) equivalent to 0.175 mg.

  • The other ingredients are: all-rac-α-tocopherol (E307), medium chain triglycerides, glycerol, gelatine, Opacode® White imprinting ink (consisting of: shellac (E904), titanium dioxide (E171) and simethicone), Sunset Yellow FCF (E110). What InVita D3 looks like and contents of pack

InVita D3 1,000 IU soft capsules

InVita D3 1,000 IU is a dark red, oval-shaped, soft capsule. It contains a slightly yellow oily liquid. Each capsule has “1” printed in white ink. Each carton contains 28 capsules in blister strips.

InVita D3 7,000 IU soft capsules

InVita D3 7,000 IU is a yellow, oval-shaped, soft capsule. It contains a slightly yellow oily liquid. Each capsule has “7” printed in white ink. Each carton contains 4 capsules in blister strips.

Marketing Authorisation Holder

Consilient Health Limited, Floor 3, Block 3, Miesian Plaza, Dublin 2, D02 Y754, Ireland.

Manufacturers

Consilient Health (UK) Ltd.,

1 Church Road, Richmond, TW9 2QE, United Kingdom Consilient Health Limited, Block 2A Richview Office Park, Clonskeagh, Dublin 14, D14 Y0A5, Ireland

This leaflet was last revised in January 2024.

P1659

Client : Consilient Health Ltd.

Project : Dec 2023

Item(s) : InVita D3 7,000 IU soft capsules

Size : 160 x 240 mm

Software : InDesign CC

FONTS

Myriad Pro

BiomeW01-Regular

DESIGNED BY

Minty

PLEASE NOTE : PAPER COPIES ARE SUPPLIED AS A VISUAL REFERENCE ONLY. DO NOT MATCH FOR COLOUR

CONSILIENT CODE : P1659

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 24837/0072

Last revision stated in the text: January 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Invita D3 7 000 IU soft capsules

Active substance Colecalciferol
Strength 7 000 IU
Pharmaceutical form Yellow, oval-shaped, soft capsule. It contains a slightly yellow oily liquid. Each capsule has “7” printed in white ink. Capsule dimensions are 10.6mm x 7mm.
Excipients all-rac-α-tocopherol (E307), Medium Chain Triglycerides, Glycerol (E422), Gelatine, Sunset Yellow FCF (E110), Opacode® White imprinting ink, Shellac (E904), Titanium dioxide (E171), Simethicone
Shelf life 30 months
Storage Do not store above 25°C.
Store in original packaging in order to protect from light.
Drug group (ATC) Vitamin D and analogues, colecalciferol
Marketing authorisation PL 24837/0072 (first authorised 31 May 2022)
Marketing authorisation holder Consilient Health Limited

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.